Custom Antibody

Global Market Trajectory & Analytics

MCP21591

EXECUTIVE ENGAGEMENTS

OUTREACH

562
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

112
Interactions with Platform & by Email

PARTICIPANTS

22
Unique # Participated

VALIDATIONS

11
Responses Validated*

COMPETITORS

32
Responses Validated*

BRANDS

0
Responses Validated*
* Login for a full stack data experience

DATE

FEB 2021

TABLES

210

PAGES

272

EDITION

8

PRICE

USD $5600


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Custom Antibody estimated at US$330.3 Million in the year 2020, is projected to reach a revised size of US$552.1 Million by 2027, growing at a CAGR of 7.6% over the analysis period 2020-2027. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$208.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyclonal Antibodies segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
The Custom Antibody market in the U.S. is estimated at US$89.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$122.9 Million by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
In the global Recombinant Antibodies segment, USA, Canada, Japan, China and Europe will drive the 7.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$47.2 Million in the year 2020 will reach a projected size of US$78.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$76.2 Million by the year 2027, while Latin America will expand at a 9.6% CAGR through the analysis period.

SELECT PLAYERS

Abcam PLC; Agilent Technologies, Inc.; Biolegend, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Genscript; Innovagen Ab; Merck Group; Promab Biotechnologies, Inc.; Proteogenix

SEGMENTS

» Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies) » End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Contract Research Organizations)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Custom Antibody Competitor Market Share Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Custom Antibody by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Custom Antibody by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Custom Antibody by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Polyclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Recombinant Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Recombinant Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Recombinant Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
Market Facts & Figures
USA Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
Europe Current & Future Analysis for Custom Antibody by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Custom Antibody by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Custom Antibody by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Custom Antibody by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Custom Antibody by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Custom Antibody by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
India Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Custom Antibody by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Custom Antibody by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Custom Antibody by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Custom Antibody by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Custom Antibody by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Custom Antibody by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Custom Antibody by Type - Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Custom Antibody by Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom Antibodies for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Custom Antibody by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Custom Antibody by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Contract Research Organizations for the Years 2012, 2020 & 2027
Total Companies Profiled: 32

General queries: Info411@StrategyR.com